Concepedia

Thomas Wilde

TW

Statistics

Publications

9

Citations

350

H-Index

9

Active since

2001

Affiliations

Frederick National Laboratory for Cancer Research(Current)

Science Applications International Corporation (United States)

Janssen (United States)

University of Maryland, Baltimore County

Janssen (Belgium)

Thomas Wilde is an author at Frederick National Laboratory for Cancer Research specializing in pharmacy, pharmacology, and life sciences.

Publications per year

2001–2021

9

Publications

9

PABA/NO as an Anticancer Lead:  Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity

Joseph E. Saavedra, Aloka Srinivasan, Gregory S. Buzard et al. · Journal of Medicinal Chemistry · 2006 · 91 citations · Full text

, , +17

Single ocular injection of a sustained-release anti -VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model

Peter Adamson, Thomas Wilde, Eric Dobrzynski et al. · Journal of Controlled Release · 2016 · 59 citations · Full text

, , +17

Hydrolytic Reactivity Trends among Potential Prodrugs of the O<sup>2</sup>-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial Activity

Carlos A. Valdez, Joseph E. Saavedra, Brett M. Showalter et al. · Journal of Medicinal Chemistry · 2008 · 41 citations · Full text

, , +11

Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534

Xiaohua Xue, Aimee De Leon-Tabaldo, Rosa Luna-Roman et al. · Scientific Reports · 2021 · 38 citations · Full text

, , +17

Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound

Harinath Chakrapani, Thomas Wilde, Michael L. Citro et al. · Bioorganic & Medicinal Chemistry · 2007 · 30 citations · Full text

, , +17

1–5 of 9